Breen WG, Dixon JG, Anderson SK, Sarkaria JN, et al. Final Report on NCCTG N0877 (Alliance): A Phase II Randomized, Placebo-Controlled Trial of Chemoradiotherapy with or without Dasatinib for Glioblastoma. Neuro Oncol 2025 Jun 28:noaf156. doi: 10.1093.
PMID: 40579995